| Trial ID: | L4863 |
| Source ID: | NCT01303055
|
| Associated Drug: |
Alogliptin
|
| Title: |
Effects of Alogliptin on Pancreatic Beta Cell Function
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Alogliptin|DRUG: Metformin 750 mg
|
| Outcome Measures: |
Primary: beta cell function evaluated from 75 g OGTT, 75 g OGTT: glucose level, blood insulin level, c-peptide immunoreactivity (pre-test, 30 mins, 60 mins, 120 mins), fasting blood proinsulin Oral glucose tolerance test ( OGTT ) will be conducted before, a year after, and two years after the beginning of the trial., 2 years | Secondary: 1,5-AG level, Secondary end points include HbA1c level., 2 years
|
| Sponsor/Collaborators: |
Sponsor: Aichi Gakuin University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
80
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2011-02
|
| Completion Date: |
2014-12
|
| Results First Posted: |
|
| Last Update Posted: |
2011-02-24
|
| Locations: |
Dept. of Intern. Med., School of Dentistry, Aichi Gakuin University, Nagoya, Aichi, 464-8650, Japan|Tosaki Clinic for Diabetes and Endocrinology, Nagoya, Aichi, 468-0009, Japan|Diabetes Clinic, Okazaki East Hospital, Okazaki, Aichi, 444-0008, Japan|Diabetes Center, Yokkaichi Social Insurance Hospital, Yokkaichi, Mie, 510-0016, Japan
|
| URL: |
https://clinicaltrials.gov/show/NCT01303055
|
